𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort

✍ Scribed by Carina Wattmo, Åsa K Wallin, Lennart Minthon

Book ID
119896885
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
225 KB
Volume
12
Category
Article
ISSN
1471-2377

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypertension, white matter change and re
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
✍ Peter J. Connelly; Neil P. Prentice; Kenneth G. Fowler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Background Cholinesterase inhibitors are used to treat mild to moderate Alzheimer's disease. Their role in patients with concurrent cerebrovascular disease has been less well studied, and the influence of vascular risk factors on response to treatment is uncertain. We investigated the effect of hype

Switching cholinesterase inhibitor thera
Switching cholinesterase inhibitor therapy in Alzheimer's disease—donepezil to rivastigmine, is it worth it?
✍ Roger Bullock; Claire Connolly 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

Switching from donepezil to rivastigmine was bene®cial in cognitive and global terms in 55.0% of the patients with Alzheimer's disease studied. \* Side-effects on donepezil and rivastigmine were independent of one another. \* It may be possible to extend the positive effects that cholinesterase inhi